Abstract:Background: Cancer-associated fibroblasts (CAFs) are one of the major components of prostate stromal cells, which play a crucial part in tumor development and treatment resistance. This study aimed to establish a model of CAFs-related microRNAs (miRNAs) to assess prognostic differences, tumor microenvironments, and screening of anticancer drugs by integrating data from single-cell RNA sequencing (scRNA-seq) and bulk RNA sequencing (buRNA-seq). Methods: scRNA-seq and buRNA-seq data of primary prostate cancer (PCa) were downloaded from Gene Expression Omnibus and The Cancer Genome Atlas databases. Statistical methods including Least absolute shrinkage and selection operator (Lasso), Lasso penalized, Random Forest, Random Forest Combination, and Support Vector Machine (SVM) were performed to select hub miRNAs. Pathway analyses and assessment of infiltrating immune cells were conducted using Gene Set Enrichment Analysis and the CIBERSORT algorithm. The expression of CAFs-related miRNAs in fibroblast cell lines were validated through quantitative real-time PCR. Cell Counting Kit 8 (CCK8), wound-healing, clone formation, and cell migration assays were used to explore cell proliferation, growth, and migration in vitro. A mouse xenograft model was established to investigate the effect of CAFs on tumor growth in vivo. Results: Through single-cell transcriptomics analysis in 34 PCa patients, 89 CAFs-related mRNAs were identified. A prognostic model based on 9 CAFs-related miRNAs (hsa-miR-1258, hsa-miR-133b, hsa-miR-222-3p, hsa-miR-145-3p, hsa-miR-493-5p, hsa-miR-96-5p, hsa-miR-15b-5p, hsa-miR-106b-5p, and hsa-miR-191-5p) was established to predict biochemical recurrence (BCR). We have determined through two prediction methods that NVP-TAE684 may be the optimal targeted therapy drug for treating CAFs. Downregulation of hsa-miR-106b-5p in CAFs significantly suppressed cell proliferation, migration, and colony formation in vitro. In vivo studies using a xenograft model further confirmed that hsa-miR-106b-5p downregulation significantly reduced tumor growth. Conclusion: Our findings conducted an integrated bioinformatic analysis to develop a CAFs-related miRNAs model that provides prognostic insights into individualized and precise treatment for prostate adenocarcinoma patients. Downregulation of miR-106b-5p in CAFs significantly suppressed tumor growth, suggesting a potential therapeutic target for cancer treatment.

miRNA expression analysis of cancer - associated fibroblasts and normal fibroblasts in colorectal cancer

MiRNA expression analysis of cancer-associated fibroblasts and normal fibroblasts in breast cancer.

[Primary Culture and Characteristics of Colorectal Cancer-Associated Fibroblasts].

Characteristics of Primary Cancer Associated Fibroblasts and Normal Fibroblasts and Their Effects on Colorectal Cancer EMT

Initial Study of Microrna Expression Profiles of Colonic Cancer Without Lymph Node Metastasis.

Expression miRNAs in cancer associated fibroblasts of gastric cancer and their effects on the migration and invasion

Differential Expression of Colon Cancer MicroRNA in Microarry Study

Analysis of miRNA expression profiles in colorectal cancer based on high-throughput sequencing

Identification of Differentially Expressed MicroRNAs involved in the Pathogenesis of Colorectal Cancer.

Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.

MicroRNAs in Colorectal Cancer As Markers and Targets: Recent Advances.

Expression profile of microRNAs in human colon cancer stem cells

miRNA expression profile of colon cancer stem cells compared to non-stem cells using the SW1116 cell line.

Microrna Expression Profiles In Human Colorectal Cancers With Liver Metastases

Differential Microrna Expression Profiling in Primary Tumors and Matched Liver Metastasis of Patients with Colorectal Cancer

Effects of CAF-Derived MicroRNA on Tumor Biology and Clinical Applications

Novel circulating microRNAs expression profile in colon cancer: a pilot study

Co-modulated behavior and effects of differentially expressed miRNA in colorectal cancer

Reprogramming of Normal Fibroblasts into Cancer-Associated Fibroblasts by miRNAs-Mediated CCL2/VEGFA Signaling

Identification of miRNA signature in cancer-associated fibroblast to predict recurrent prostate cancer

Systematic identification of cancer-associated-fibroblast-derived genes in patients with colorectal cancer based on single-cell sequencing and transcriptomics